Correlation between Serum High-Sensitivity C-Reactive Protein Level and Severity of Albuminuria Measured by Urine Albumin-to-Creatinine Ratio in Type 2 Diabetic Patients
Downloads
Introduction: One of complications in type 2 diabetes mellitus (DM) that require high treatment cost is diabetic kidney disease (DKD), which is characterized by the presence of albuminuria, decrease in glomerular filtration rate, or both. Researches show a positive correlation between type 2 DM and serum high-sensitivity C-reactive protein (hs-CRP) level, a sensitive marker of subclinical inflammation. This study aimed to analyze the correlation between serum hs-CRP level and severity of albuminuria measured by urine albumin-to-creatinine ratio (ACR).
Methods: The study was conducted at the Endocrinology Outpatient Clinic of Dr. Soetomo General Academic Hospital, Surabaya, on June-July 2020.
Results: The study included 50 patients with type 2 DM, consisting of 25 (50%) men and 25 (50%) women, with median age of 58.0 (42-68) years and mean body mass index (BMI) of 21.91 ± 1.310 kg/m2. Median duration of DM was 12.0 (6-22) years, median HbA1c level was 7.20% (5.7%-12.3%), mean serum crEatinine level was 0.83 ± 0.180 mg/dL, and median estimated glomerular filtration rate (eGFR) value was 92.85 (61.6-121.2) mL/minute/1.73 m2. Median serum hs-CRP level was 1.20 (0.1-4.0) mg/L and median urine ACR value was 49.570 (7.78-426.00) mg/g. Normoalbuminuria was detected in 28% of subjects, microalbuminuria in 66% of subjects, and macroalbuminuria in 6% of subjects. This study showed positive and significant correlation between serum hs-CRP level and severity of albuminuria (r = 0.701; p = <0.001).
Conclusion: There was positive and significant correlation betweeen serum hs-CRP level and severity of albuminuria in type 2 diabetic patients.
Alicic RZ, Rooney MT, Tuttle KR. Diabetic Kidney Disease: Challenges, Progress, and Possibilities. Clinical Journal of American Society of Nephrology. 13, 2017, pp. 1-14.
Aryan Z, Ghajar A, Faghihi-Kashani S, Afarideh M, Nakhjavani M, Esteghamati A. Baseline High-Sensitivity C-Reactive Protein Predicts Macrovascular and Microvascular Complications of Type 2 Diabetes: A Population-Based Study. Annals of Nutrition and Metabolism. 2018, pp. 287-95.
Aslam M, Chandrasekhara P. Correlation of Fibrinogen and hs-CRP with Microvascular Complications of Type 2 Diabetes Mellitus. International Journal of Health Sciences and Research. 6, 2016, Vol. 5, pp. 25-32.
Bhowmick K, Kutty AVM, Shetty HV. Glycemic Control Modifies the Association between Microalbuminuria and C-Reactive Protein in Type 2 Diabetes Mellitus. Indian Journal of Clinical Biochemistry. 22, 2007, Vol. 2, pp. 53-9.
Chauhan R, Singh R, Lal R. Correlation of hs-CRP with Urinary Albumin Creatinin Ratio (UACR) in Patients of Diabetes with and without Nephropathy. IOSR Journal of Dental and Medical Sciences. 16, 2017, Vol. 4, pp. 51-4.
Chen F, Wang J, Liu X, Ma X, Zhang X, Huang T, Ma D, Wang Q. Levels of Inflammatory Cytokines in Type 2 Diabetes Patients with Different Urinary Albumin Excretion Rates and Their Correlation with Clinical Variables. Journal of Diabetes Research. 2013, pp. 1-6.
Gupta A, Kumar D, Rajvanshi S, Kumar A, Arya TVS. To Study the Association of High Sensitivity C-Reactive Protein with Newly Diagnosed DM Type 2. Journal of Indian Academy of Clinical Medicine. 16, 2015, Vol. 1, pp. 12-8.
Harbuwono DS, Pramono LA, Yunir E, Subekti I. Obesity and Central Obesity in Indonesia: Evidence from A National Health Survey. Medical Journal of Indonesia. 27, 2018, pp. 114-20.
Heerspink HJL, Kropelin TF, Hoekman J, de Zeeuw D. Drug-Induced Reduction in Albuminuria is Associated with Subsequent Renoprotection: A Meta-Analysis. Journal of American Society of Nephrology. 26, 2015, Vol. 8, pp. 2055-64.
Jiang L, Huang W, Liang Y, Wang F, Duan X, Yang X, Wen J, Wang N. Metabolic Syndrome, C-Reactive Protein and Microalbuminuria in a Rural Chinese Population: A Cross-Sectional Study. BMC Nephrology. 14, 2013, p. 118.
KDIGO (Kidney Disease Improving Global Outcomes). KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Official Journal of the International Society of Nephrology. 3, 2012, Vol. 1, pp. 1-150.
Miroliaee A, Nasiri-Toosi M, Khalilzadeh O, Esteghamati A, Abdollahi A, Mazloumi M. Disturbances of Parathyroid Hormone-Vitamin D Axis in Non-Cholestatic Chronic Liver Disease: A Cross-Sectional Study. Hepatology International. 4, 2010, pp. 634-40.
Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon III RO, Criqui M, Fadl YY, Fortman SP, Hong Y, Myers GL, Rifai N, Smith Jr SC, Taubert K, Tracy RP, Vinicor F. Markers of Inflammation and Cardiovascular Disease. Circulation. 107, 2003, pp. 499-511.
Persson F, Rossing P. Diagnosis of Diabetic Kidney Disease: State of the Art and Future Perspective. Kidney International Supplements. 8, 2018, pp. 2-7.
Pojskic L, Hasic S, Tahto E, Arnautovic-Torlak V, Pojskic B. Influence of C-Reactive Protein on the Occurrence and Assessing of Albuminuria Severity in Diabetics. Medicinski Glasnik (Zenica). 15, 2018, Vol. 1, pp. 1-7.
Sabanayagam C, Lee J, Shankar A, Lim SC, Wong TY, Tai ES. C-Reactive Protein and Microalbuminuria in a Multi-ethnic Asian Population. Nephrology Dialysis Transplantation. 25, 2009, pp. 1167-72.
Sproston NR, Ashworth JJ. Role of C-Reactive Protein at Sites of Inflammation and Infection. Frontiers in Immunology. 9, 2018, p. 754.
Tuttle KR, Bakris GL, Bilous RW, Chiang JL, de Boer IH, Goldstein-Fuchs J, Hirsch IB, Kalantar-Zadeh K, Narva AS, Navaneethan SD, Neumiller JJ, Patel UD, Ratner RE,Whaley-Connell AT, Molitch ME. Diabetic Kidney Disease: A Report from an ADA Consensus Conference. Diabetes Care. 37, 2014, pp. 2864-83.
Tutuncu Y, Satman I, Celik S, Dinccag N, Karsidag K, Telci A, Genc S, Issever H, Tuomilehto J, Omer B. A Comparison of hs-CRP Levels in New Diabetes Groups Diagnosed Based on FPG, 2-hPG, or HbA1c Criteria. Journal of Diabetes Research. 2016, pp. 1-9.
Uemura H, Katsuura-Kamano S, Yamaguchi M, Bahari T, Ishizu M, Fujioka M, Arisawa K. Relationships of Serum High-Sensitivity C-Reactive Protein and Body Size with Insulin Resistance in a Japanese Cohort. PLoS ONE. 12, 2017, Vol. 6, p. e0178672.
Volker D, Grunhage F, Wagenpfeil S, Lammert F, Stokes CS. Serum 25-Hydroxyvitamin D Levels and Mortality Risk in Patients with Liver Cirrhosis: A Protocol for A Systemic Review and Meta-analysis of Observational Studies. Systematic Reviews. 8, 2019, Vol. 73, pp. 1-6.
Wan X, Zhang L, Gu H, Wang S, Liu X. The Association of Serum hs-CRP and Urinary Alpha1-Microglobulin in Patients with Type 2 Diabetes Mellitus. BioMed Research International. 2019, pp. 1-10.
Wang Z, Hoy WE, Wang Z. The Correlates of Urinary Albumin to Creatinine Ratio (ACR) in a High Risk Australian Aboriginal Community. BMC Nephrology. 14, 2013, p. 176.
Yang S, Liu J, Yi B, Mao J, Zhang X, Liu Y, Lei D, Gui M, Zhang H. Elevated High Sensitivity C-Reactive Protein Increases the Risk of Microalbuminuria in Subjects with Cardiovascular Disease Risk Factors. Therapeutic Apheresis and Dialysis. 2017, pp. 1-8.
Yorulmaz E, Uzunlulu M, Alpaslan B, Oguz A. hs-CRP for Cardiovascular Risk in Diabetes: Problems in Daily Practice. Turkish Journal of Endocrinology and Metabolism. 2, 2006, pp. 35-38.
Zylka A, Dumnicka P, Kusnierz-Cabala B, Gala-Bladzinska A, Ceranowicz P, Kucharz J, Zabek-Adamska A, Maziarz B, Drozdz R, Kuzniewski M. Markers of Glomerular and Tubular Damage in the Early Stage of Kidney Disease in Type 2 Diabetic Patients. Mediators of Inflammation. 2018, pp. 1-12.
Copyright (c) 2023 Dicky Febrianto
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Copyright (c) Author
1. The journal allows the author to hold the copyright of the article without restrictions.
2. The journal allows the author(s) to retain publishing rights without restrictions.
3. The formal legal aspect of journal publication accessibility refers to Creative Commons Atribution-Share Alike 4.0 (CC BY-SA).
